Frederick G. Vogt
Interim CEO & General Counsel at Iovance Biotherapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Iovance Biotherapeutics Inc., 2 years.
Iovance Biotherapeutics Inc.
Director · Interim CEO & General Counsel
Chief executive roles
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +15,625 | — | — |
| Jun 5, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −6,638 | $4.23 | $28,079 |
| Jun 1, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +41,668 | — | — |
| Jun 1, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −17,701 | $3.96 | $70,096 |
| Mar 5, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +62,493 | — | — |
| Mar 5, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −26,755 | $4.58 | $122,538 |
| Mar 2, 2026 | Iovance Biotherapeutics Inc. | Option exercise | +52,087 | — | — |
| Mar 2, 2026 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −22,809 | $3.79 | $86,446 |
| Dec 2, 2025 | Iovance Biotherapeutics Inc. | Option exercise | +10,417 | — | — |
| Dec 2, 2025 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −4,426 | $2.14 | $9,472 |
| Dec 1, 2025 | Iovance Biotherapeutics Inc. | Option exercise | +41,669 | — | — |
| Dec 1, 2025 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −17,701 | $2.23 | $39,473 |
| Sep 2, 2025 | Iovance Biotherapeutics Inc. | Option exercise | +52,086 | — | — |
| Sep 2, 2025 | Iovance Biotherapeutics Inc. | Shares withheld for tax | −22,127 | $2.19 | $48,458 |
| Jun 2, 2025 | Iovance Biotherapeutics Inc. | Option exercise | +52,085 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.